Research Projects
Filters
Filters for Projects
Research Units
Next-generation therapeutics inspired by parasitic helminths. (Old ID 27418)
This project utilises helminth secretomes to develop: (i) anti-helminth vaccines; (ii) diagnostics for helminth infections; and (iii) helminth secreted moieties for treating autoimmune and metabolic diseases. The end goal is to discover and develop innovative vaccines, diagnostics and immunotherapeutics sources from helminth secretomes.
Finally new tools are available to combat drug resistant tuberculosis, but how do we make them work? Models to determine effective implementation strategies in Australia and our region (Old ID 27632)
Multi-drug resistant tuberculosis (MDR TB) is a growing concern which may make TB elimination impossible if not addressed head-on. Strategies to control MDR are available or in trial including: • MDR diagnostics • MDR directed treatment • New vaccines However, the best way to operationalise these new tools in different settings to maximise impact remains uncertain. Mathematical modelling, data analysis and health economics can play a role in assisting the fight to eliminate TB by providing insights into best deployment of TB strategies depending on the setting. My work is to combine best evidence with country context (health system,TB burden and costs, to simulate TB epidemiology and test possible interventions and their impact "in silico". This project will undertake 3 streams of activity Stream 1 Control of MDR TB in high burden settings: I will develop models to assess how new tools can best be used to impact on the MDR TB epidemic in high incidence regions. This will consider the new short course regimens for active MDR TB and the value of levofloxacin to treat latent TB, as well as emerging therapeutics and vaccines. Stream 2. Optimal drug combinations for MDR treatment: I will develop pharmacokinetic / pharmacodynamic models to investigate whether low, high or adaptive dosing of levofloxacin leads to the best outcome in treating MDR TB. Stream 3. How can new tools for MDR best be deployed in Australia? This work will address the large pool of latently infected people in Australia, and large proportion of TB arising from immigration, including those with latent MDR TB. Through two Centres for Research Excellence, I will collaborate with Australia's leading tuberculosis clinical trialists, policy makers, health systems experts, clinicians and pharmacologists to analyse the data arising from recent and current clinical trials, particularly relating to the use of drugs to tackle MDR TB.
Life and death of Australopithicus sediba: how a potential ancestor ended up dead in a cave in world heritage site in South Africa (Old ID 20796)
In August 2008 the remarkable Malapa fossil site was discovered with remains of the first and only fossils of Australopithecus sediba - a potential direct human ancestor. The fossils are in an exceptional state of preservation, and excavations will start in late 2013, creating a unique opportunity to develop a detailed understanding of the chemical, physical and biological factors that led to burial and fossilisation. This research will focus on the complex interplay between termites, sediment chemistry, landscape conditions and palaeo-climate as contributing factors to fossil preservation. Results will document the environment in which sediba lived and died, and assist future exploration for hominid fossils.
Maximising genetic growth potential of barramundi in different culture environments. (Old ID 22428)
Good Fortune Bay Fisheries (GFB) is Australia's largest farmed barramundi producer. GFB operates two farms, one located north of Bowen where barramundi are reared in a high density. Brackish water raceway culture system and the other in Kelso, where fish are reared in freshwater earthen ponds. The company holds the largest number of barramundi stock in the country and is Queensland's largest hatchery facility. Given a need to maintain domestic and international competitiveness GFB has identified genetic improvement of their stocks as the highest R&D priority for the company. Due to the unique culture systems they farm barramundi in, however, GFB recognise there are critical knowledge gaps that need to be overcome before they can produce an improved strain that maximises genetic gain under both culture environments (marine/freshwater & pond/raceway).
Portable Polycyclic Aromatic Hydrocarbon (PAH) Detection (Old ID 22435)
Polycyclic aromatic hydrocarbons (PAHs) are toxic contaminants in the Great Barrier Reef (GBR) especially in areas near industrial, port and shipping activities. PAH monitoring is costly and complex. A portable technology for the quick detection of environmentally persistent and toxic PAHs will be developed using a new colourimetric detection technology based on photochromic compounds. This technology has been successfully used for sensing nitroaromatic-based explosives and will here be applied to strongly UV-absorbing PAHs. This work will be performed in collaboration with an end-user: Australian Maritime Safety Authority (AMSA).
Tropical Disease - immunity, pathogenesis and vaccine development: global translation. (Old ID 22490)
Malaria, helminths and streptococci are poorly controlled and neglected pathogens of global significance causing major morbidity and mortality - particularly in disadvantaged communities. This Program brings together a multidisciplinary team of scientists and clinicians who will leverage their unparalleled understanding of tropical health, microbiology and pathogenesis of these infections to develop new therapeutics and vaccines. The Program has both standard and unique animal models and unrivalled access to controlled human experimental infections, clinical trials and longitudinal field studies to define the impact of infection on the host immune response.
Building a simulation model to improve cardiovascular disease risk prediction and treatment for indigenous Australians (Old ID 22925)
This project will use a large linked cohort of 2800 Indigenous adults from north Queensland remote communities which looks at reasons for the excess cardiovascular risk in this group. The aim is to get better measures of risk of heart disease and premature death which can be done by primary health care services for better early detection and better management and survival.
NESP 3.7 Barriers to Restoration and NbS (Old ID 28996)
Coastal and marine restoration in Australia has been hindered by the ability for project managers to obtain approval. This project examines the barriers and challenges presenting project managers keen to begin restoration projects. The project will work through a series of case studies from SA, Tasmania, NSW and QLD focusing on oyster and tidal ingress project approaches. The outcomes of this research will outline areas in policy requiring changes and identify a consistent approach for project managers working in several states across Australia.
Incorporating genome editing into the aquaculture industry in Australia (Old ID 29013)
Professor Jehee Lee from Jeju International University, South Korea has agreed to allow me to visit his lab and receive extensive training in genome editing. He has successfully genetically edited numerous species of fish to optimise and select for commercial traits valuable to the aquaculture industry. Visiting with Professor Lee, as well as with other members of his lab, would allow me to gain the techniques and skills necessary to develop a general protocol applicable for a variety of aquaculture species.
Protecting north Queensland from Aedes albopictus, an exotic dengue vector, with Attractive Targeted Sugar Baits (ATSB) (Old ID 26789)
Aedes albopictus, a documented vector of dengue, Zika and chikungunya, is one of the fastest spreading invasive species worldwide, and was first detected in the Torres Strait in 2005. This pilot project will lay the foundation required to assess the feasibility of Attractive Targeted Sugar Baits (ATSB) to control Aedes albopictus. The overall objective is to determine the frequency that mosquitos’ sugar feed, a parameter critical to the success of ATSBs. This pilot data will be leveraged for funding to trial the use of ATSBs to stop Ae. albopictus from reaching the mainland.
